Evommune (EVMN) Times Interest Earned (2024 - 2026)
Evommune (EVMN) posted quarterly Times Interest Earned of -$0.26 for Q1 2026, up 99.65% year-over-year from -$0.13 in Q1 2025, and down 100.04% quarter-over-quarter from $691.07 in Q4 2025.
Powered by 
Analysis
Evommune (EVMN) Times Interest Earned (2024 - 2026) Analysis & Trends
Evommune (EVMN) has reported Times Interest Earned for 3 consecutive years, with -$0.26 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned rose 99.65% year-over-year to -$0.26; the TTM figure through Mar 2026 stood at -$0.89 (changed N/A YoY), while the FY2025 annual figure was -$1.49, up 98.3% from the prior year.
- Times Interest Earned fell to -$0.26 in Q1 2026 per EVMN's latest filing, from $691.07 in the prior quarter.
- Across five years, Times Interest Earned topped out at $691.07 in Q4 2025 and bottomed at -$3575.7 in Q4 2024.
- Historically, Times Interest Earned has averaged -$655.59 across 3 years, with a median of -$38.54 in 2025.
- Annual changes were most pronounced in 2025 — Times Interest Earned soared 119.33% — and 2026, when it surged 99.65%.
- Evommune's Times Interest Earned stood at -$3575.7 in 2024, then jumped by 119.33% to $691.07 in 2025, then tumbled by 100.04% to -$0.26 in 2026.
- Business Quant data shows EVMN's Times Interest Earned at -$0.26 in Q1 2026, $691.07 in Q4 2025, and -$1.93 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 1.42 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -0.08 |
| 10 | Evommune | 445.37 Mn | 244.58 Mn | - | -17,447.50 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17,447.50 |
| Mar 31, 2026 | -5,988.50 |
| Sep 30, 2025 | -1,480.89 |
| Jun 30, 2025 | -851.63 |
| Mar 31, 2025 | -1,156.31 |
| Dec 31, 2024 | 21,454.00 |
| Sep 30, 2024 | -971.59 |